Enrique María Ocio (Enrique M Ocio)

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 16

Top Venues

British journal of haematology

Cancers

Leukemia

Cells

Hospital Universitario Marqués de Valdecilla

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario Marqués de Valdecilla Sep 17o 2018

Spain

Head of the Department :: Hematology

Publications

Enrique María Ocio, Aurore Perrot, Pierre Bories, Jesús San F Miguel, Igor W Blau, Lionel Karlin, Joaquin Martinez-Lopez, Song-Yau Wang, Sara Bringhen, Magda Marcatti, Maria-Victoria Mateos-Manteca, Paula Rodriguez-Otero, Stefania Oliva, Axel Nogai, Nadia Le Roux, Liyan Dong, Sandrine Macé, Matthieu Gassiot, Thomas Fitzmaurice, Corina Oprea, Phillipe Moreau
Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation. Leukemia (2023)
Marc-Steffen Raab, Yael C Cohen, Schjesvold Fredrik, Kimberly Aardalen, Adwait Oka, Andrew Spencer, Martin Wermke, Anita D Souza, Jonathan L Kaufman, Anna Maria Cafro, Enrique María Ocio, Noriko Doki, Kristin Henson, Gina Trabucco, Ana Carrion, Florent C Bender, Pierre-Eric Juif, Adonai Fessehatsion, Liqiong Fan, Jeffrey P Stonehouse, John W Blankenship, Brian Granda, Serena De Vita, Haihui Lu
Preclinical discovery and initial clinical data of WVT078, a BCMA × CD3 bispecific antibody. Leukemia (2023)
Enrique María Ocio, Omar Nadeem, Fredrik Schjesvold, Francesca Gay, Cyrille Touzeau, Meletios- Athanasios Dimopoulos, Paul G Richardson, Maria-Victoria Mateos-Manteca
Melflufen for the treatment of multiple myeloma. Expert review of clinical pharmacology 15 (4) (2022)
Rosalinda Termini, David Zihala, Evangelos Terpos, Albert Perez-Montaña, Tomas Jelinek, Marc-Steffen Raab, Niels Weinhold, Elias Karl Mai, Anna Luise Grab, Jill Corre, François Vergez, Antonio Sacco, Marco Chiarini, Viviana Giustini, Alessandra Tucci, Sara Rodriguez, Cristina Moreno, Cristina Perez, Catarina Maia, Esperanza Martín-Sánchez, Camilla Guerrero, Cirino Botta, Juan-José Garcés, Aitziber Lopez, Luis-Esteban Tamariz-Amador, Felipe Prosper, Joan Bargay, Maria-Elena Cabezudo, Enrique María Ocio, Roman Hájek, Joaquin Martinez Lopez, Fernando Solano, Rebeca Iglesias, Artur Paiva, Catarina Geraldes, Helena Vitoria, Clara Gomez, Felipe De Arriba, Heinz Ludwig, Antoni Garcia-Guiñon, María Casanova, Adrian Alegre, Valentín Cabañas, Maialen Sirvent, Albert Ortiol, Javier de la Rubia, Jose-Ángel Hernández-Rivas, Luis Palomera, Maria Sarasa, Pablo Rios, Noemi Puig, Maria-Victoria Mateos-Manteca, Juan A Flores-Montero, Alberto Orfao, Hartmut Goldschmidt, Herve Avet-Loiseau, Aldo M Roccaro, Jesús San F Miguel, Juan José Lahuerta, null null
Circulating Tumor and Immune Cells for Minimally Invasive Risk Stratification of Smoldering Multiple Myeloma. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (21) (2022)
Julio Dávila-Valls, Verónica González-Calle, Fernando Escalante, Seila Cerdá, Noemí Puig, Miriam Santero, Abelardo Bárez, Carmen Montes, Rosa López, José María Alonso, Carlos Aguilar, Aránzazu García-Mateo, Jorge Labrador, Carmen Aguilera, Alfonso García-Coca, Roberto Hernández, Maria-Victoria Mateos-Manteca, Enrique María Ocio
Recovery of polyclonal immunoglobulins during treatment in patients ineligible for autologous stem-cell transplantation is a prognostic marker of longer progression-free survival and overall survival. British journal of haematology 198 (2) (2022)
Esperanza M Algarín, Dalia Quwaider, Francisco J Campos-Laborie, Andrea Díaz-Tejedor, Pedro Mogollón, Elena Vuelta, Montserrat Martín-Sánchez, Laura San-Segundo, Lorena González-Méndez, Norma C Gutiérrez, Miriam Santero, Teresa Paíno, Javier De Las Rivas, Enrique María Ocio, Mercedes Garayoa
Stroma-Mediated Resistance to S63845 and Venetoclax through MCL-1 and BCL-2 Expression Changes Induced by miR-193b-3p and miR-21-5p Dysregulation in Multiple Myeloma. Cells 10 (3) (2021)
Patricia Maiso, Pedro Mogollón, Enrique María Ocio, Mercedes Garayoa
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression. Cancers 13 (11) (2021)
Daniel Alameda, Ibai Goicoechea, Marco Vicari, Elena Arriazu, Alice Nevone, Sara Rodriguez, Marta Lasa, Noemi Puig, Maria Teresa Cedena, Diego Alignani, Sonia Garate, David Lara-Astiaso, Amaia Vilas-Zornoza, Sarai Sarvide, Enrique María Ocio, Ramon Lecumberri, Alfonso Garcia de Coca, Jorge Labrador, Maria-Esther Gonzalez, Luis Palomera, Mercedes Gironella, Valentín Cabañas, Maria Casanova, Albert Ortiol, Isabel Krsnik, Albert Perez-Montaña, Javier de la Rubia, José Enrique de la Puerta, Felipe de Arriba, Vito Michele Fazio, Joaquin Martinez Lopez, Juan-José Lahuerta, Maria-Victoria Mateos-Manteca, Maria-Dolores Odero, Felipe Prosper, Assaf Weiner, Ido Amit, Mario Nuvolone, Jesús San F Miguel, Juan José Lahuerta
Tumor cells in light-chain amyloidosis and myeloma show distinct transcriptional rewiring of normal plasma cell development. Blood 138 (17) (2021)
María-Victoria Mateos, Joan Bladé, Sara Bringhen, Enrique María Ocio, Yvonne Efebera, Luděk Pour, Francesca Gay, Pieter Sonneveld, Joachim Gullbo, Paul G Richardson
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma. Journal of clinical medicine 9 (10) (2020)
Ramón García-Sanz, Irene Dogliotti, Gian Maria Zaccaria, Enrique María Ocio, Araceli Rubio, Ilda Murillo, Fernando Escalante, Carmen Aguilera, Aránzazu García-Mateo, Alfonso García de Coca, Roberto Hernández, Julio Dávila, Noemi Puig, María García-Álvarez, María Del Carmen Chillón, Miguel Alcoceba, Alejandro Medina, Verónica González de la Calle, María Eugenia Sarasquete, Marcos González, Norma Carmen Gutiérrez, Cristina Jiménez
6q deletion in Waldenström macroglobulinaemia negatively affects time to transformation and survival. British journal of haematology 192 (5) (2020)
Enrique María Ocio, Cristina Motlló, Paula Rodríguez-Otero, Joaquin Martinez-Lopez, Mª José Cejalvo, Jesús Martín-Sánchez, Joan Bladé, Mª Dolores García-Malo, Mª Victoria Dourdil, Aránzazu García-Mateo, Felipe de Arriba, Ramón García-Sanz, Javier de la Rubia, Albert Oriol, Juan-José Lahuerta, Jesús San F Miguel, Maria-Victoria Mateos-Manteca
Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group. British journal of haematology 192 (3) (2020)
Teresa Paíno, Lorena González-Méndez, Laura San-Segundo, Luis-Antonio Corchete, Susana Hernández-García, Andrea Díaz-Tejedor, Esperanza M Algarín, Pedro Mogollón, Montserrat Martín-Sánchez, Norma C Gutiérrez, María-Victoria Mateos, Mercedes Garayoa, Enrique María Ocio
Protein Translation Inhibition is Involved in the Activity of the Pan-PIM Kinase Inhibitor PIM447 in Combination with Pomalidomide-Dexamethasone in Multiple Myeloma. Cancers 12 (10) (2020)
Noemí Puig, Luis-Antonio Corchete, José J Pérez-Morán, Julio Dávila-Valls, Teresa Paíno, Javier de la Rubia, Albert Ortiol, Jesús Martín-Sánchez, Felipe de Arriba, Joan Bladé, María-Jesús Blanchard, Verónica González De La Calle, Miriam Santero, Bruno Paiva, Juan-José Lahuerta, Jesús F San-Miguel, Maria-Victoria Mateos-Manteca, Enrique María Ocio
Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial. Cancers 12 (12) (2020)
Maria-Victoria Mateos-Manteca, Robert Z Orlowski, Enrique María Ocio, Paula Rodríguez-Otero, Donna Reece, Phillipe Moreau, Nikhil Munshi, David E Avigan, David S Siegel, Razi Ghori, Mohammed Z H Farooqui, Patricia Marinello, Jesús San F Miguel
Pembrolizumab combined with lenalidomide and low-dose dexamethasone for relapsed or refractory multiple myeloma: phase I KEYNOTE-023 study. British journal of haematology 186 (5) (2019)
Pedro Mogollón, Andrea Díaz-Tejedor, Esperanza M Algarín, Teresa Paíno, Mercedes Garayoa, Enrique María Ocio
Biological Background of Resistance to Current Standards of Care in Multiple Myeloma. Cells 8 (11) (2019)
Esperanza Macarena Algarín, Susana Hernández-García, Mercedes Garayoa, Enrique María Ocio
Filanesib for the treatment of multiple myeloma. Expert opinion on investigational drugs 29 (1) (2019)

Enrique María Ocio.css-eqlu8i{font-size:small;padding-left:4px;} (Enrique M Ocio)

Publication Activity (10 Years)

Top Topics

Top Venues

Enrique María Ocio (Enrique M Ocio)